Navigation Links
Kendle Named Best CRO for Second Consecutive Year by Leading Global Pharmaceutical Publication Scrip
Date:12/12/2007

Company's ability to build and maintain successful partnerships, patient recruitment expertise and its global reach cited as reasons for selection

CINCINNATI, Dec. 12 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization (CRO), today announced it was named "Best CRO" at the Scrip Awards held Dec. 4 in London. Kendle was selected from among leading global CROs by a distinguished panel of pharmaceutical industry executives. The annual awards competition, organized by Scrip World Pharmaceutical News, a leading provider of news and analysis for the global biopharmaceutical industry, is designed to recognize new standards of excellence and celebrate achievements that reflect cutting-edge science and the intellectually exciting and socially rewarding nature of the industry. This is the second year in a row Kendle has received the "Best CRO Award."

(Logo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGO )

"Kendle is honored to be recognized once again by the Scrip expert panel as 'Best CRO'," noted Candace Kendle, PharmD, Chairman and Chief Executive Officer. "In a service business it's all about people, and at Kendle our associates offer exceptional qualities that make a real difference to our customers."

According to Scrip World Pharmaceutical News, "The judges felt that among Kendle's strengths are its ability to build and maintain successful partnerships, its global reach, patient recruitment expertise, its skills in core therapeutic areas as well as niche areas and its extensive pregnancy registry."

Selection criteria for the award included performance across multiple categories, including range of capabilities, exceeding sponsor expectations, ability to build solid long-term working relationships within biopharmaceutical companies, quality of data management and innovative strategies for regulatory guidance. In their deliberations, the judges looked at the range of services provided by the entrants, measures they have implemented to improve their performance or offer new services and the quality of their relationships with their customers.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is among the world's leading global clinical research organizations. We deliver innovative and robust clinical development solutions -- from first-in-human studies through market launch and surveillance -- to help the world's biopharmaceutical companies maximize product life cycles and grow market share.

Our global clinical development business is focused on five regions -- North America, Europe, Asia/Pacific, Latin America and Africa -- to meet customer needs. We have conducted clinical trials and provided regulatory and pharmacovigilance services in more than 80 countries. The company was named the "Top CRO to Work With" in the Thomson CenterWatch 2007 Survey of U.S. Investigative Sites. Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from the company's Web site at http://www.kendle.com.


'/>"/>
SOURCE Kendle International Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Kendle to Ring Opening Bell at NASDAQ Stock Market on August 22
2. Kendle Marks 10th Anniversary as Public Company With NASDAQ Opening Bell Ceremony and Investor Day Event
3. Kendle to Present at Thomas Weisel Partners Healthcare Conference 2007
4. Kendle to Present at Bear Stearns 20th Annual Healthcare Conference
5. Kendle to Present at the UBS Global Life Sciences Conference
6. Kendle to Present at the Natixis Bleichroeder Hidden Gems Conference
7. Kendle Invites You to Attend Its Third Quarter 2007 Earnings Conference Call and Webcast
8. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
9. Todd R. Nelson Named Chief Executive Officer of eBioscience, Inc.
10. Miaxis Biometrics Named as Red Herring 100 Asia Award Winner for 2007
11. Dr. Keith Wilson Named President and Chief Scientific Officer of Takeda San Diego
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 2016  Sequenom, Inc. (NASDAQ: SQNM ), ... through the development of innovative products and services, announced ... United States denied its petition to review ... Sequenom,s U.S. Patent No. 6,258,540 (",540 Patent") are not ... the Supreme Court,s Mayo Collaborative Services v. Prometheus Laboratories ...
(Date:6/27/2016)... Raleigh, NC (PRWEB) , ... June 27, 2016 ... ... a mission to bring innovative medical technologies, services and solutions to the healthcare ... development and implementation of various distribution, manufacturing, sales and marketing strategies that are ...
(Date:6/27/2016)...   Ginkgo Bioworks , a leading organism ... today awarded as one of the World Economic ... most innovative companies. Ginkgo Bioworks is engineering biology ... world in the nutrition, health and consumer goods ... customers including Fortune 500 companies to design microbes ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and ... and the 6000i models are higher end machines that use the more unconventional z-dimension ... light beam from the bottom of the cuvette holder. , FireflySci has developed ...
Breaking Biology Technology:
(Date:6/3/2016)... 3, 2016 Das ... Nepal hat ein 44 ... geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, ... Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte ... Januar teilgenommen, aber Decatur wurde als konformste ...
(Date:5/24/2016)... Calif. , May 24, 2016 Ampronix facilitates superior patient care by ... LMD3251MT  3D medical LCD display is the latest premium product recently added to the ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a provider ... MegaMatcher Automated Biometric Identification System (ABIS) , ... multi-biometric projects. MegaMatcher ABIS can process multiple complex ... any combination of fingerprint, face or iris biometrics. ... SDK and MegaMatcher Accelerator , which ...
Breaking Biology News(10 mins):